败血症
脂多糖
医学
免疫学
促炎细胞因子
蛋白激酶B
PI3K/AKT/mTOR通路
免疫系统
感染性休克
肿瘤坏死因子α
药理学
炎症
MAPK/ERK通路
信号转导
生物
细胞生物学
作者
Xiangyang Qin,Xinru Jiang,Xin Jiang,Yuli Wang,Zhulei Miao,Weigang He,Gui‐Zhen Yang,Zhenhui Lv,Yizhi Yu,Yuejuan Zheng
摘要
Sepsis is the principal cause of fatality in the intensive care units worldwide. It involves uncontrolled inflammatory response resulting in multi-organ failure and even death. Micheliolide (MCL), a sesquiterpene lactone, was reported to inhibit dextran sodium sulphate (DSS)-induced inflammatory intestinal disease, colitis-associated cancer and rheumatic arthritis. Nevertheless, the role of MCL in microbial infection and sepsis is unclear. We demonstrated that MCL decreased lipopolysaccharide (LPS, the main cell wall component of Gram-negative bacteria)-mediated production of cytokines (IL-6, TNF-α, MCP-1, etc) in Raw264.7 cells, primary macrophages, dendritic cells and human monocytes. MCL plays an anti-inflammatory role by inhibiting LPS-induced activation of NF-κB and PI3K/Akt/p70S6K pathways. It has negligible impact on the activation of mitogen-activated protein kinase (MAPK) pathways. In the acute peritonitis mouse model, MCL reduced the secretion of IL-6, TNF-α, IL-1β, MCP-1, IFN-β and IL-10 in sera, and ameliorated lung and liver damage. MCL down-regulated the high mortality rate caused by lethal LPS challenge. Collectively, our data illustrated that MCL enabled maintenance of immune equilibrium may represent a potentially new anti-inflammatory and immunosuppressive drug candidate in the treatment of sepsis and septic shock.
科研通智能强力驱动
Strongly Powered by AbleSci AI